Scientists test 'Living' vaginal probiotic that could block HIV
Prevention
Recruiting now
This early-stage study is testing the safety of a vaginal probiotic called MucoCept-CVN, which is designed to prevent HIV infection in women. The probiotic contains a modified bacteria that continuously produces an anti-HIV drug. Researchers will enroll 12 healthy women to test d…
Phase: PHASE1 • Sponsor: Craig Cohen, MD, MPH • Aim: Prevention
Last updated Mar 12, 2026 13:51 UTC